Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by María D. García-Lizana
Patients With Non-Valvular Atrial Fibrillation on Vitamin K Antagonists or Direct-Acting Oral Anticoagulants: Patients Profile and Long-Term Follow-Up Outcomes
Archivos de cardiolog�a de M�xico (English ed. Internet)
Related publications
Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion
Journal of Clinical Trials in Cardiology
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Comparison Between Long-Term Clinical Outcomes of Vitamin K Antagonist and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Novel Anticoagulants Versus Vitamin K Antagonists for Cardioversion of Non- Valvular Atrial Fibrillation – A Meta-Analysis of More Than 17000 Patients
Scientific Reports
Multidisciplinary
Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?
Clinical pharmacology and therapy
Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants
Journal of Medical Economics
Health Policy
